SUN PHARMACEUTICAL INDUSTRIES LTD 13D and 13G filings for Taro Pharmaceutical Industries Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-24 07:27 am Unchanged |
2024-06-24 | 13D | Taro Pharmaceutical Industries Ltd. TARO |
SUN PHARMACEUTICAL INDUSTRIES LTD | 29,497,813 100.000% |
0 (Unchanged) |
Filing |
| 2024-01-17 4:35 pm Unchanged |
2024-01-17 | 13D | Taro Pharmaceutical Industries Ltd. TARO |
SUN PHARMACEUTICAL INDUSTRIES LTD | 29,497,813 78.480% |
0 (Unchanged) |
Filing |
| 2023-12-11 4:30 pm Unchanged |
2023-12-10 | 13D | Taro Pharmaceutical Industries Ltd. TARO |
SUN PHARMACEUTICAL INDUSTRIES LTD | 29,497,813 78.480% |
0 (Unchanged) |
Filing |
| 2023-05-26 5:01 pm Unchanged |
2023-05-26 | 13D | Taro Pharmaceutical Industries Ltd. TARO |
SUN PHARMACEUTICAL INDUSTRIES LTD | 29,497,813 78.480% |
0 (Unchanged) |
Filing |
| 2022-09-08 2:54 pm Unchanged |
2021-08-02 | 13D | Taro Pharmaceutical Industries Ltd. TARO |
SUN PHARMACEUTICAL INDUSTRIES LTD | 29,497,813 78.480% |
0 (Unchanged) |
Filing |